or
forgot password
  • cancer clinical trials in hartford, CT

  • Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
    Hartford Hospital
    Hartford, Connecticut 06102-5037
    Breast Cancer
    Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Hartford, Connecticut 06102-5037
    Endometrial Cancer
    Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Cervical Cancer
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    Hartford Hospital
    Hartford, Connecticut 06102-5037
    Prostate Cancer, Hormone Refractory Prostate Cancer
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Breast Cancer
    Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Cervical Cancer
    Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Hartford, Connecticut 06102-5037
    Cervical Cancer
    Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy
    Connecticut Surgical Group
    Hartford, Connecticut 06106
    Impotence, Prostate Cancer
    Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Hartford, Connecticut 06102-5037
    Sarcoma
    Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma
    GSK Investigational Site
    Hartford, Connecticut 06106
    Metastatic Melanoma
    Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Leukemia
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas
    Oncology Associates, PC
    Hartford, Connecticut 06106
    Pancreatic Cancer, Neoplasm Metastasis, Adenocarcinoma
    Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab
    Hartford Hospital, Cancer Clinical Research Office
    Hartford, Connecticut 06102
    Hemoglobinuria, Paroxysmal
    Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Hartford Hospital, Cancer Clinical Research Office
    Hartford, Connecticut 06102
    Paroxysmal Hemoglobinuria, Nocturnal
    Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
    Hartford Hospital, Cancer Clinical Research Office
    Hartford, Connecticut 06102
    Hemoglobinuria, Paroxysmal
    Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer
    Hartford Hospital
    Hartford, Connecticut 06102-5037
    Prostate Cancer
    Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
    Connecticut Childrens Medical Center
    Hartford, Connecticut 06106
    Cancer, Breakthrough Pain
    Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
    Connecticut Childrens Medical
    Hartford, Connecticut 06106
    Pain, Cancer, Sickle Cell Anemia, Severe Burns
    Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Stage I Lymphoepithelioma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Relapsed Leukemia
    Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer
    GSK Investigational Site
    Hartford, Connecticut 06106
    Ovarian Cancer, Neoplasms, Ovarian
    Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
    GSK Investigational Site
    Hartford, Connecticut 06106
    Neoplasms, Prostate, Prostate Cancer
    Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Hartford, Connecticut 06102-5037
    Sarcoma
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
    Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Lymphoma
    Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
    Hartford Hospital Cancer Clinical Research Office
    Hartford, Connecticut 06102
    Cachexia
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Leukemia
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Pancreatic Cancer
    Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Pancreatic Cancer
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site 103
    Hartford, Connecticut 06105
    Hypoactive Sexual Desire Disorder
    Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Brain and Central Nervous System Tumors
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Breast Cancer
    Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myelomonocytic Leukemia (M4), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    ChemoFx® PRO - A Post-Market Data Collection Study
    Hartford Hospital
    Hartford, Connecticut 06102-5037
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Uterine Neoplasms, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Cervical Cancer
    Dasatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Cognition in the Study of Tamoxifen and Raloxifene
    Hartford Hospital
    Hartford, Connecticut 06102-5037
    Cognition, Aging
    American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Hartford, Connecticut 06102-5037
    Leukemia
    Spectroscopic Evaluation of Cervical Neoplasia
    Saint Francis Hospital
    Hartford, Connecticut 06112
    Cervical Neoplasia
    Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Lung Cancer
    Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Lung Cancer
    Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Hartford, Connecticut 06102-5037
    Endometrial Cancer
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Hartford, Connecticut 06102-5037
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
    SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Lymphoma
    S0309, Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma, Waldenstrom's Macroglobulinemia, Amyloidosis, or Monoclonal Gammopathy of Undetermined Significance
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition
    S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer
    Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Lymphoma
    Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Colorectal Cancer
    Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Breast Cancer
    Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Colorectal Cancer, Metastatic Cancer
    AMG 386 in Treating Patients With Persistent or Recurrent Endometrial Cancer
    Hartford Hospital
    Hartford, Connecticut 06102-5037
    Endometrial Cancer
    Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
    Hartford Hospital

    Trial Locations
    Hartford Hospital
    Saint Francis Hospital and Medical Center
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    Brivanib in Treating Patients With Persistent or Recurrent Cervical Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Cervical Cancer
    Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Gliosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Osteosarcoma
    LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib
    St. Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Non-Small Cell Lung Cancer